VIR Stock Analysis: Buy, Sell, or Hold?
VIR - Vir Biotechnology, Inc. Common Stock
$7.44
-0.34 (-4.37%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 25, 2026
24d
Get Alerted When VIR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called VIR this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VIR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: VIR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: VIR is currently trading at $7.44, which is considered extended relative to its 30-day fair value range of $5.77 to $7.16.
Technical Outlook: Technically, VIR is in a uptrend. Immediate support is located at $5.79, while resistance sits at $7.80. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: VIR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.11 (+119.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VIR is in a uptrend. Immediate support is located at $5.79, while resistance sits at $7.80. Short-term momentum is weak, with the stock down 4.4% recently.
Market Sentiment: VIR has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.11 (+119.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$5.77 -
$7.16
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding VIR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-4.4%)
- BULLISH: Trading 119.9% below Wall St target ($17.11)
Fair Price Analysis
30-Day Fair Range
$5.77 -
$7.16
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$5.80
Resistance Level
$7.81
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-2.66
Wall Street Target
$17.11
(+119.9%)
Revenue Growth (YoY)
-89.9%
Earnings Growth (YoY)
58.5%
Last updated: January 31, 2026 1:04 AM ET
Data refreshes hourly during market hours. Next update: 2:04 AM
Data refreshes hourly during market hours. Next update: 2:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VIR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
14
Sells
Net
INSIDERS SELLING
Recent Transactions
Endurance (Cayman) Ltd S…
SELL
154383 shares
2025-10-23
Endurance (Cayman) Ltd S…
SELL
144266 shares
2025-10-22
Endurance (Cayman) Ltd S…
SELL
109675 shares
2025-10-21
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$91 | 59 HOLD |
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$22 | 60 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1035 | 58 HOLD |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$83 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$33 | 60 HOLD |
Advanced VIR Option Strategies
Professional options setups generated by AI based on today's VIR price and gamma walls.
